Nycomed Prepares To Launch First Nonprescription PPI With EU-Wide Approval
This article was originally published in The Tan Sheet
Executive Summary
Nycomed is gearing up to launchPantozol Control (pantoprazole 20 mg) later this year when the firm expects an approval for European Union nonprescription marketing authorization